Katharina Koch

727 total citations
19 papers, 417 citations indexed

About

Katharina Koch is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Katharina Koch has authored 19 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Katharina Koch's work include Pluripotent Stem Cells Research (6 papers), Epigenetics and DNA Methylation (4 papers) and Glioma Diagnosis and Treatment (4 papers). Katharina Koch is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), Epigenetics and DNA Methylation (4 papers) and Glioma Diagnosis and Treatment (4 papers). Katharina Koch collaborates with scholars based in Germany, United States and China. Katharina Koch's co-authors include Jarek Maciaczyk, Ulf D. Kahlert, Abigail K. Suwala, Charles G. Eberhart, Hans‐Jakob Steiger, Ellen Fritsche, Julia Hartmann, Dieter Willbold, Rudolf Hartmann and Donata Maciaczyk and has published in prestigious journals such as SHILAP Revista de lepidopterología, Small and British Journal of Cancer.

In The Last Decade

Katharina Koch

19 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katharina Koch Germany 11 237 164 85 79 73 19 417
Lanchun Ni China 13 228 1.0× 120 0.7× 130 1.5× 45 0.6× 32 0.4× 20 464
Ann‐Christin Nickel Germany 12 192 0.8× 115 0.7× 62 0.7× 57 0.7× 75 1.0× 24 339
Inés Sáenz‐de‐Santa‐María Spain 13 273 1.2× 134 0.8× 54 0.6× 44 0.6× 63 0.9× 20 453
Pítia Flores Ledur Brazil 10 217 0.9× 61 0.4× 135 1.6× 99 1.3× 65 0.9× 11 441
Ching-Fang Chang Taiwan 12 285 1.2× 145 0.9× 70 0.8× 78 1.0× 34 0.5× 18 571
Cécile Thirant France 13 408 1.7× 170 1.0× 114 1.3× 141 1.8× 22 0.3× 18 594
Shabierjiang Jiapaer Japan 9 270 1.1× 154 0.9× 160 1.9× 66 0.8× 36 0.5× 12 456
Tércia Alves Brazil 9 246 1.0× 83 0.5× 114 1.3× 67 0.8× 36 0.5× 10 470
Kevin J. Pridham United States 13 349 1.5× 102 0.6× 62 0.7× 58 0.7× 32 0.4× 23 485
Mario Mauri Italy 12 356 1.5× 90 0.5× 98 1.2× 69 0.9× 41 0.6× 30 587

Countries citing papers authored by Katharina Koch

Since Specialization
Citations

This map shows the geographic impact of Katharina Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Koch more than expected).

Fields of papers citing papers by Katharina Koch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Koch. The network helps show where Katharina Koch may publish in the future.

Co-authorship network of co-authors of Katharina Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Koch. A scholar is included among the top collaborators of Katharina Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Koch. Katharina Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Koch, Katharina, et al.. (2025). Nuclear hormone receptors control fundamental processes of human fetal neurodevelopment: Basis for endocrine disruption assessment. Environment International. 198. 109400–109400. 3 indexed citations
2.
Carstens, Kelly E., Jui‐Hua Hsieh, Kristina Bartmann, et al.. (2025). A comparative study of biostatistical pipelines for benchmark concentration modeling of in vitro screening assays. Computational Toxicology. 34. 100360–100360. 1 indexed citations
3.
4.
Ramachandran, Haribaskar, Philipp Westhoff, Andrea Rossi, et al.. (2024). HiPSC-derived 3D neural models reveal neurodevelopmental pathomechanisms of the Cockayne Syndrome B. Cellular and Molecular Life Sciences. 81(1). 368–368. 4 indexed citations
5.
6.
Hartmann, Julia, Ines Lauria, Farina Bendt, et al.. (2022). Alginate‐Laminin Hydrogel Supports Long‐Term Neuronal Activity in 3D Human Induced Pluripotent Stem Cell‐Derived Neuronal Networks. Advanced Materials Interfaces. 10(6). 9 indexed citations
7.
Klose, Jördis, Farina Bendt, Ulrike Hübenthal, et al.. (2022). Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro. Cell Biology and Toxicology. 39(1). 319–343. 5 indexed citations
8.
Koch, Katharina, et al.. (2022). Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation. SHILAP Revista de lepidopterología. 4. 816370–816370. 15 indexed citations
9.
Nickel, Ann‐Christin, Daniel Picard, Andrea Rossi, et al.. (2022). Progenitor cells derived from gene‐engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology. Biotechnology Journal. 17(6). e2100693–e2100693. 1 indexed citations
10.
Koch, Katharina, Rudolf Hartmann, Abigail K. Suwala, et al.. (2021). Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs). Cancers. 13(23). 6001–6001. 12 indexed citations
11.
Fritsche, Ellen, Thomas Haarmann‐Stemmann, Julia Hartmann, et al.. (2020). Stem Cells for Next Level Toxicity Testing in the 21st Century. Small. 17(15). e2006252–e2006252. 57 indexed citations
12.
Neumann, Silke, Katharina Koch, Donata Maciaczyk, et al.. (2020). Enzymatic Activity of CD73 Modulates Invasion of Gliomas via Epithelial–Mesenchymal Transition-Like Reprogramming. Pharmaceuticals. 13(11). 378–378. 20 indexed citations
13.
Koch, Katharina, Rudolf Hartmann, Ann‐Christin Nickel, et al.. (2020). A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity. Cell Death Discovery. 6(1). 20–20. 63 indexed citations
14.
Suwala, Abigail K., Katharina Koch, Isabella Ogorek, et al.. (2018). Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro. Oncotarget. 9(32). 22703–22716. 54 indexed citations
15.
Maciaczyk, Donata, Daniel Picard, Lili Zhao, et al.. (2017). CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells. British Journal of Cancer. 117(1). 102–112. 36 indexed citations
16.
Koch, Katharina, Rudolf Hartmann, Friederike Schröter, et al.. (2016). Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells. Oncotarget. 7(45). 73414–73431. 26 indexed citations
17.
Kahlert, Ulf D., Abigail K. Suwala, Katharina Koch, et al.. (2015). Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells. Journal of Neuropathology & Experimental Neurology. 74(9). 889–900. 58 indexed citations
18.
Kahlert, Ulf D., Menglin Cheng, Katharina Koch, et al.. (2015). Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells. International Journal of Cancer. 138(5). 1246–1255. 34 indexed citations
19.
Kahlert, Ulf D., Katharina Koch, Abigail K. Suwala, et al.. (2015). The effect of neurosphere culture conditions on the cellular metabolism of glioma cells. Folia Neuropathologica. 3(3). 219–225. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lanchun Ni Breakdown of academic impact, for papers by Ann‐Christin Nickel Breakdown of academic impact, for papers by Inés Sáenz‐de‐Santa‐María Breakdown of academic impact, for papers by Pítia Flores Ledur Breakdown of academic impact, for papers by Ching-Fang Chang Breakdown of academic impact, for papers by Cécile Thirant Breakdown of academic impact, for papers by Shabierjiang Jiapaer Breakdown of academic impact, for papers by Tércia Alves Breakdown of academic impact, for papers by Kevin J. Pridham Breakdown of academic impact, for papers by Mario Mauri
Rankless by CCL
2026